Stock News - Fortress Biotech, Inc. $FBIOP
Latest Stock News for $FBIOP
Fortress Biotech Reports 2025 Financial Results with Key Corporate Developments
Expected Stock impact: Noticeably Positive
2026-03-31 20:17:38
Fortress Biotech's Subsidiary Cyprium Therapeutics Closes $205 Million Sale of Rare Pediatric Disease Priority Review Voucher
Expected Stock impact: Very Positive
2026-03-30 22:18:44
